Is Cholesteryl Ester Transfer Protein Inhibition an Effective Strategy to Reduce Cardiovascular Risk? CETP Inhibition as a Strategy to Reduce Cardiovascular Risk: The Pro Case.

Subjects

Subjects :

Amides
Animals
Benzodiazepines therapeutic use
Cardiovascular Diseases physiopathology
Cholesterol Ester Transfer Proteins deficiency
Cholesterol Ester Transfer Proteins genetics
Disease Models, Animal
Esters
Humans
Lipid Metabolism, Inborn Errors genetics
Lipid Metabolism, Inborn Errors physiopathology
Mice
Oxazolidinones therapeutic use
Quinolines therapeutic use
Rabbits
Risk Factors
Sulfhydryl Compounds therapeutic use
Treatment Outcome
Anticholesteremic Agents therapeutic use
Cardiovascular Diseases epidemiology
Cardiovascular Diseases prevention & control
Cholesterol Ester Transfer Proteins antagonists & inhibitors
Cholesterol Ester Transfer Proteins physiology

Details

Language :

English

ISSN :

1524-4539

Volume :

132

Issue :

5

Database :

MEDLINE

Journal :

Circulation

Publication Type :

Academic Journal

Accession number :

26240263

Full Text :

https://doi.org/10.1161/CIRCULATIONAHA.114.014025